SCIRP Mobile Website
Paper Submission

Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.

 

Contact Us >>

Article citations

More>>

Kang, Y.B., He, W., Tulley, S., Gupta, G.P., Serganova, I., Chen, C.-R., Manova-Todorova, K., Blasberg, R., Gerald, W.L. and Massagué, J. (2005) Breast Cancer Bone Metastasis Mediated by the Smad Tumor Suppressor Pathway. Proceedings of the National Academy of Sciences of the United States of America, 102, 13909-13914.
http://dx.doi.org/10.1073/pnas.0506517102

has been cited by the following article:

  • TITLE: EMT and Anti-EMT Strategies in Cancer

    AUTHORS: M. A. Nezami, Steven Hager, Jessica Garner

    KEYWORDS: Cancer, EMT, Anti-EMT, Epigenetic, CTC, ctDNA

    JOURNAL NAME: Journal of Cancer Therapy, Vol.6 No.11, October 29, 2015

    ABSTRACT: This article discusses the role of epithelial mesenchymal transition (EMT) and addresses the scientific merits on epigenetic regulation of EMT. The importance of EMT as a prognostic biomarker is explored and the rationale on application of multitargeted epigenetic therapy is discussed. We describe a literature review of the epigenetic influence of such process and we present a potentially effective method to reverse the epigenetic switch in favor for MET, in a clinical setting. A case series of advanced solid tumors are summarized aiming at generating hypothesis for the future recommendations for clinical trials targeting the tumor’s biological behavior through inhibition of EMT. Hypothesis: We propose an integral and integrative approach that can modify tumor’s biological behavior through inhibition of EMT, and further reduce the chances of metastasis, that can translate to improved outcome and patient’s survival in advanced disease.